
Estimated global market for unproven cell therapies
CARIBBEAN · HONDURAS

Roatán, a special jurisdiction in the Caribbean Sea
SOUTHEAST ASIA · MALAYSIA

Forest City, Johor, just across the border from Singapore

Act on the Safety of Regenerative Medicine
of Japan's population is 65 or older.
projected to live with dementia by 2040
projected to have mild cognitive impairment by 2040

Top Stem Cell Research Team





Life Sciences Core Facilities (LSCF), Weizmann Institute of Science
It was one of roughly 100 labs lost
We forged ahead
MSCs release extracellular vesicles, growth factors and cytokines that mediate immunomodulatory and regenerative effects.
Priming the producer cells strengthens the anti-inflammatory signal they release and makes it consistent batch to batch.
Standard MSC
Variable signal
Primed MSC
Priming
Strong, consistent signal
Anti-inflammatory factors
miRNA cargo
Boost
Standardize
OUR DATA

Preclinical data (mouse and cell models). Investigational.


OUR DATA

Preclinical data. Investigational.
Our data

Exosomes accumulate in affected brains after intranasal delivery. Models: C57bl (healthy), ETH-1 (stroke), 6-OHDA (Parkinson's), 5xFAD (Alzheimer's), BTBR (autism).
Preclinical data (mouse and cell models). Investigational.
Finding the signal in the noise
Stem cell therapy translation platform
We pull the signal from the noise in three areas



AI to decode the therapeutic signal across biology, manufacturing, and clinical response
IDENTIFY
Which molecular features matter?
REPRODUCE
Which manufacturing conditions generate them?
VALIDATE
Which measurements demonstrate relevant biological activity?

FLAGSHIP PROTOCOL
Signal Mind flagship trial · Japan
Primed MSC-derived signal therapy, measured from baseline through scheduled follow-up.
Manufacturing
›
Partner clinic
Domestic and international patients
›
Transparent, standardized pricing
WHAT WE MEASURE
Global cognition
MoCA, MMSE, ADAS-Cog
Memory
RAVLT (Rey Auditory Verbal Learning Test)
Attention and executive function
Trail Making A and B, Digit Symbol
Daily function and staging
CDR-SB, ADCS-ADL
Biomarkers and neuroimaging
MRI volumetrics, FDG-PET
Patient and caregiver reports
Structured questionnaires

Next in line

Following
Develop protocols
Partner clinics deliver
Measure outcomes
License to more clinics
Market ambition
US · Israel · Japan
ADVISORS
Prof. Gadi Turgeman
Ariel University
Prof. Dani Offen
Tel Aviv University
Dr. Takahiro Ochiya
Tokyo Medical University

CEO
Proven VC backed biotech entrepreneur in biomanufacturing and gene and cell therapy.

COO
Bioinformatics and AI background with extensive operator experience.

CSO
Leading aging scientist and Weizmann PhD.

signal.clinic
SIGNAL
Making stem cell therapy
accessible to humanity